Historical record - last NADAC effective date: 3/20/2019
Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0386 per EA under NDC 76282020830. Its NADAC has been published 280 times since Nov 28, 2013.
FDA first approved this application on Oct 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282020830
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/20/2019
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077534FDA Approved
10/3/2006
TE Code
AB
On Market Since
10/1/2012
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 280 times since Nov 28, 2013, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0386 per EA |
|---|---|
| All-time high | $0.0464 (Feb 12, 2014) |
| All-time low | $0.0353 (Sep 19, 2018) |
| Median price | $0.0385 |
| Average price | $0.0388 |
| Largest weekly change | +10.2% (Jan 22, 2014) |
| Weeks tracked | 280 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-3.1%
Last surveyed Apr 3, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0386 per EA (NDC 76282020830), effective Apr 3, 2019.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has declined 3.1%. It has been tracked across 280 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since Nov 28, 2013, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0353 (Sep 19, 2018) to a high of $0.0464 (Feb 12, 2014), with a median of $0.0385 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CITALOPRAM HBR 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 76282020830) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.